Compugen (CGEN) Times Interest Earned (2011 - 2025)
Compugen (CGEN) posted quarterly Times Interest Earned of $70.41 for Q4 2025, up 103421.4% year-over-year from N/an in Q4 2024, and up 452.6% on a QoQ basis from -$19.97 in Q2 2025.
Compugen (CGEN) Times Interest Earned (2011 - 2025) Analysis & Trends
Compugen has reported Times Interest Earned for 15 years, with the latest figure at $70.41 in Q4 2025.
- Times Interest Earned for Q4 2025 came in at $70.41, up 103421.4% year-over-year; the trailing twelve-month figure through Dec 2025 was $39.35 (up 29121.89% YoY), and the FY2025 annual result was $0.56, up 514.97% from the prior year.
- Times Interest Earned rose to $70.41 in Q4 2025, from -$19.97 in the prior quarter.
- Over five years, Times Interest Earned peaked at $70.41 in Q4 2025 and troughed at -$19.97 in Q2 2025.
- A 5-year average of $5.74 and a median of -$0.07 in 2024 frame the typical range for Times Interest Earned.
- The widest annual swing landed in 2021, when Times Interest Earned tumbled 2562.74%; it then jumped 103421.4% in 2025.
- A 5-year view of Times Interest Earned shows it stood at -$2.64 in 2021, then surged by 98.75% to -$0.03 in 2022, then soared by 28603.03% to $9.41 in 2023, then plunged by 100.72% to -$0.07 in 2024, then jumped by 103421.4% to $70.41 in 2025.
- Per Business Quant data, the three most recent Times Interest Earned figures were $70.41 in Q4 2025, -$19.97 in Q2 2025, and -$0.07 in Q4 2024.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Times Interest Earned (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn | 2.84 |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn | 24.64 |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn | - |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - | -0.19 |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn | 8.18 |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn | -0.01 |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - | 0.61 |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn | 2.82 |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn | -0.08 |
| 10 | Compugen | 227.88 Mn | 136.13 Mn | 352,000.00 | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 1.01 |
| Jun 30, 2025 | -19.97 |
| Dec 31, 2024 | -0.07 |
| Jun 30, 2024 | -16.93 |
| Dec 31, 2023 | 0.17 |
| Dec 31, 2022 | -0.03 |
| Dec 31, 2021 | -0.09 |
| Dec 31, 2020 | -0.10 |
| Dec 31, 2019 | -0.09 |
| Jun 30, 2019 | -4.97 |
| Dec 31, 2018 | -0.14 |
| Jun 30, 2018 | -6.16 |
| Dec 31, 2017 | -6.88 |
| Jun 30, 2017 | -10.06 |
| Dec 31, 2016 | -0.15 |
| Jun 30, 2016 | -6.82 |
| Dec 31, 2015 | -0.01 |
| Dec 31, 2014 | -0.02 |
| Dec 31, 2013 | -0.07 |
| Dec 31, 2012 | -0.08 |